Peptide market finally ripening?
Peptide drugs look like they may finally fulfil their promise, after years of what has largely been disappointment, if figures released in a new market research report prove accurate.
Archives for January 13, 2005
DNA fraud-buster aimed at pharma sector
Applied DNA Sciences, a specialist in the use of DNA as a security and anti-counterfeiting technology, is to work with the US Department of Energy to develop an improved process for identifying its marker technology that should bring down...
Qiagen launches protein sample preparation kits
Qiagen has announced a new product line for the separation, purification and handling of nucleic acids, an essential process in drug discovery, which aims to improve over current applied methods, which suffer from decreased sensitivity and unreliability.
EU puts cash behind nanobiotechnology
A new European project on the emerging discipline of nanobiotechnology aims to tackle the thorny issue of safety as well as develop new materials for drug delivery and other medical uses, reports Phil Taylor.
Rosy outlook for generic API sector?
The market for low-cost generic drugs looks set to be buoyant for the foreseeable future, both in Europe as a whole and in France, according to Hubert Olivier, president of the French subsidiary of the leading German generics group Ratiopharm.
Chiron hoping for vaccine plant inspections
Chiron said yesterday that the UK and US regulatory authorities are expected to conduct a series of inspections of its manufacturing facility in Liverpool, which was forced to cease production of influenza vaccines last year, leading to shortages.